PubMed=18371388; DOI=10.1016/j.stem.2007.10.004
Crook J.M., Peura T.T., Kravets L., Bosman A.G., Buzzard J.J., Horne R., Hentze H., Dunn N.R., Zweigerdt R., Chua F., Upshall A., Colman A.
The generation of six clinical-grade human embryonic stem cell lines.
Cell Stem Cell 1:490-494(2007)

PubMed=20177998; DOI=10.1007/s11626-010-9287-1
Sivarajah S., Raj G.S., Mathews A.J.V., Sahib N.B.E., Hwang W.-S., Crook J.M.
The generation of GLP-grade human embryonic stem cell banks from four clinical-grade cell lines for preclinical research.
In Vitro Cell. Dev. Biol. Anim. 46:210-216(2010)

PubMed=22265736; DOI=10.1016/j.scr.2011.10.001
Funk W.D., Labat I., Sampathkumar J., Gourraud P.-A., Oksenberg J.R., Rosler E.S., Steiger D., Sheibani N., Caillier S., Stache-Crain B., Johnson J.A., Meisner L.F., Lacher M.D., Chapman K.B., Park M.J., Shin K.-J., Drmanac R., West M.D.
Evaluating the genomic and sequence integrity of human ES cell lines comparison to normal genomes.
Stem Cell Res. 8:154-164(2012)

PubMed=28445466; DOI=10.1038/nature22312
Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C., Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G., Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A., Eggan K.C.
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations.
Nature 545:229-233(2017)